Press releases

ERIE, CO – Building on its pioneering leadership in space biology, Sachi Bio today announced the award of a prestigious NASA InSPA (In Space Production Applications) Phase 2 contract . This milestone follows the successful completion of the InSPA Phase 1 contract , further accelerating the development of Sachi Bio’s proprietary Nanoligomer™ platform—a programmable RNA therapeutic discovery engine designed to tackle the world's most devastating conditions, from ALS and Alzhe

Sachi Bio's Nanoligomers offer potential neurological countermeasures and treatment of terrestrial neurological diseases

Sachi Bio proudly participated in the recent ALS Walk held in Denver, Colorado, organized by the ALS United Rocky Mountain, standing in...

[Erie, CO] – May 28, 2025 – Sachi Bio, a leading biotechnology company developing RNA-based therapeutics, has been awarded a Therapeutic...

In recent years, the link between space exploration and the pharmaceutical industry has captured significant interest. One area that...

Sachi Bio plans to utilize brain organoids in microgravity, which is the state of apparent weightlessness experienced during free fall or...

KEYWORDS: Alzheimer’s, aging, dementia, treatment, Nanoligomer Read more at: Denver Post Colorado State University Press release DENVER -...

As the brain gets older or in conditions like Alzheimer’s, inflammation becomes a major problem that damages brain cells, leading to...